GANESHBE — Ganesh Benzoplast Balance Sheet
0.000.00%
- IN₹6.26bn
- IN₹5.93bn
- IN₹3.74bn
- 93
- 58
- 12
- 57
Annual balance sheet for Ganesh Benzoplast, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 461 | 482 | 391 | 987 | 1,024 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 417 | 526 | 382 | 785 | 954 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,221 | 1,150 | 1,512 | 2,034 | 2,309 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,216 | 2,301 | 2,984 | 3,586 | 3,739 |
| Net Goodwill | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,780 | 3,976 | 5,334 | 6,766 | 7,235 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 803 | 732 | 972 | 1,012 | 1,053 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,456 | 1,170 | 1,765 | 1,750 | 1,852 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,324 | 2,805 | 3,568 | 5,016 | 5,383 |
| Total Liabilities & Shareholders' Equity | 3,780 | 3,976 | 5,334 | 6,766 | 7,235 |
| Total Common Shares Outstanding |